Dalibor Sames Net Worth (Estimated)

Who is Dalibor Sames?

Dalibor Sames is a founder of Gilgamesh Pharmaceuticals, which was part of the Y Combinator S20 batch.

Highlights:

• Harvard University
• Stanford University
• Nobel Prize-winning research

About Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Model inputs

• Stage: series-a
• Valuation tier: raise-10x
• Funding input: reported raise $60.0M
• Valuation note: Leftover $60M homepage scrape matches the published spinout Series A. Lock A, not the prior $39M B and not AbbVie’s up-to-$1.2B asset deal.
• Research as-of: 2026-09-14
• Funding source: https://www.prnewswire.com/news-releases/gilgamesh-pharma-closes-oversubscribed-60-million-series-a-to-develop-next-generation-neuropsychiatric-therapies-302723671.html

FAQ: Dalibor Sames net worth and Gilgamesh Pharmaceuticals valuation

What is Dalibor Sames's net worth?

Dalibor Sames's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.

Dalibor Sames net worth

Dalibor Sames's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. This Dalibor Sames net worth figure is estimated paper wealth, not a verified statement of assets.

How much is Dalibor Sames worth?

Dalibor Sames's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. How much Dalibor Sames is worth here means estimated paper wealth from public company and role data — not financial advice.

How rich is Dalibor Sames?

Dalibor Sames's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. “How rich is Dalibor Sames” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.

Dalibor Sames fortune

Dalibor Sames's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. This Dalibor Sames fortune figure is estimated paper wealth only, not a verified statement of assets.

Dalibor Sames equity value

Dalibor Sames's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. Dalibor Sames equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.

What is Gilgamesh Pharmaceuticals valuation?

Gilgamesh Pharmaceuticals's estimated valuation on Entrepreneurial Check is $600.0M. Independent model output, not a verified appraisal or official mark.

What is Gilgamesh Pharmaceuticals post-money valuation?

Gilgamesh Pharmaceuticals's estimated valuation on Entrepreneurial Check is $600.0M. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.

What is Gilgamesh Pharmaceuticals funding?

Gilgamesh Pharmaceuticals funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Gilgamesh Pharmaceuticals raised is not a complete cap table — figures are estimates only.

How much did Gilgamesh Pharmaceuticals raise?

How much Gilgamesh Pharmaceuticals raised, when disclosed, informs the estimated Gilgamesh Pharmaceuticals valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.

How much money did Gilgamesh Pharmaceuticals raise?

How much money Gilgamesh Pharmaceuticals raised, when a public figure is available, is a model input for the estimated Gilgamesh Pharmaceuticals valuation on this profile. Estimates only — not a complete cap table.

What is Gilgamesh Pharmaceuticals series funding?

Gilgamesh Pharmaceuticals series funding, when a public raise is disclosed, informs the estimated Gilgamesh Pharmaceuticals valuation here. Not a complete financing history.

What company is Dalibor Sames building?

Dalibor Sames is Founder at Gilgamesh Pharmaceuticals, a Y Combinator-backed startup (batch S20).

What does Gilgamesh Pharmaceuticals do?

Gilgamesh Pharmaceuticals — Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…

What YC batch is Dalibor Sames from?

Dalibor Sames is associated with Y Combinator batch S20.

Where did Dalibor Sames go to school?

Public profiles associate Dalibor Sames with Ph.D. from Harvard University.

What other companies is Dalibor Sames connected to?

Public associations for Dalibor Sames include Gilgamesh Pharmaceuticals.

Where is Dalibor Sames based?

Public directory data lists Dalibor Sames's region as United States of America.

What industry is Dalibor Sames in?

Dalibor Sames is listed under Healthcare, Drug Discovery and Delivery.

How big is Gilgamesh Pharmaceuticals?

Public data lists Gilgamesh Pharmaceuticals's team size as 15.

What else is notable about Dalibor Sames?

Harvard University.

Is Entrepreneurial Check affiliated with Y Combinator?

No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.